Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC

Displaying 1 to 10 of 39 Posts . Displaying 10 of Posts . Page of 4 . Go To Page: . Per Page: . . . View All Sort By: .

Development of clinical diagnostic criteria for plaque psoriasis in children: An eDelphi consensus study with the International Psoriasis Council

An eDelphi study conducted by the University of Nottingham and the International Psoriasis Council identified of list of expert agreed diagnostic features the diagnosis of plaque psoriasis in children.

Read More

Biosimilars for Psoriasis - Experience from Europe

Biosimilars for Psoriasis - Experience from Europe Arnon D. Cohen, Tiago Torres, Wolf-Henning Boehncke, Menno de Rie, Denis Jullien, Luigi Naldi, Caitriona Ryan, Robert Strohal, Lone Skov, Peter van de Kerkhof, Joelle M. van der Walt, Jashin J. Wu, Claus Zachariae, Lluis Puig, Helen Young. Current Dermatology Reports (2019) 8:26–34 SUMMARY With increased use of biosimilars likely in the future, the IPC will continue to provide leadership, education, and guidance for dermatologists...

Read More

IPC 2018 Think Tank Miami Beach: A full program of scientific updates and future planning

The International Psoriasis Council (IPC) Think Tank was held at the Mondrian Hotel in Miami Beach, Florida, on November 30–December 1, where outside the air was warm, the music loud, and the clothing small, while, inside, the science sizzled and IPC councilors and invited guests engaged in a full program of scientific updates and future planning.

Read More

Now Available: 2018-2019 Global Psoriasis Atlas Annual Report

Global Psoriasis Atlas has released the annual report for April 2018- March 2019.

Read More

Long time IPC Councilor, Dr. Wayne Gulliver, awarded the Albert Neisser Lecture

Long time IPC councilor Dr. Wayne Gulliver has been awarded the 15th annual Albert Neisser Lecture.

Read More

IPC Councilor, Dr. Nick Reynolds, to deliver the Eugene Farber Lecture at the 77th Annual Meeting of the Society for Investigative Dermatology (SID)

Dr. Nick Reynolds will deliver the Eugene Farber Lecture during the 77th Annual Meeting of the Society for Investigative Dermatology (SID) on May 10, 2019 at 2:00 pm at the Hilton Chicago, International Ballroom North.

Read More

Clinical Goals and Barriers to Effective Psoriasis Care

Clinical Goals and Barriers to Effective Psoriasis Care. Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB. Dermatol Ther (Heidelb). 2019 Mar;9(1):5-18. doi: 10.1007/s13555-018-0279-5. Epub 2018 Dec 21. ABSTRACT Engaging global key opinion leaders, the International Psoriasis...

Read More

CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiographic Axial Spondyloarthritis

CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiographic Axial Spondyloarthritis Patients living with non-radiographic axial spondyloarthritis, an often undiagnosed, chronic, painful and debilitating disease, now have an approved, clinically validated treatment FDA approval was based on the C-AXSPAND Phase 3 study in adults with non-radiographic axial spondyloarthritis, which demonstrated rapid and major improvement response with...

Read More

Novartis first-in-class Cosentyx® approved in China for psoriasis patients

Novartis first-in-class Cosentyx® approved in China for psoriasis patients China Health Authority NMPA approved Cosentyx® (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy Cosentyx is the first biologic approved in China that specifically inhibits interleukin-17A (IL-17A), a cornerstone cytokine involved in the inflammation of psoriasis (PsO), psoriatic arthritis (PsA) and ankylosing spondylitis...

Read More

IPC's 2018 Annual Report Now Available

2018 was a very successful year for IPC during which we increased our global activities and impact on education. Highlights include: The successful launch of the IPC International Fellowship Program with early career dermatologist/researchers interested in psoriasis who were provided full access to the knowledge of our network of experts, representing our commitment to encouraging and supporting the next generation of psoriasis leaders; Educational symposia participation...

Read More
UPCOMING EVENT

Challenging cases in psoriasis:
A focus on pediatrics, co-morbidities, infections and biologics

Thursday, April 25, 2019
9:30 – 11:30 am
Paris, France
Register Now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

This website uses cookies. Please ensure your cookies are enabled. 
OK